Ethylglucuronide (EtG) Alcohol Testing and Detection

Ethylglucuronide, usually abbreviated EtG, is a direct metabolite of ethanol that the body produces in small quantities whenever alcohol is consumed. Because it lingers in urine long after alcohol itself has been eliminated and can also be measured in hair, fingernails, blood, and even a newborn’s first stool, EtG has become one of the most widely used biomarkers for detecting recent or chronic alcohol intake. Its appeal is straightforward: traditional markers of heavy drinking, like elevated liver enzymes, are indirect and can be thrown off by liver disease, medications, or other conditions that have nothing to do with alcohol. EtG sidesteps those problems by being a piece of the alcohol molecule itself, chemically tagged by the body. That specificity, though, comes with its own complications.

How the Body Makes EtG

When you drink, the vast majority of the ethanol you consume is broken down through oxidation in the liver, first into acetaldehyde and then into acetic acid. Less than one-tenth of a percent of the ethanol takes a different route: enzymes called UDP-glucuronosyltransferases attach a sugar molecule (glucuronic acid) to the intact ethanol, producing ethylglucuronide.¹ A parallel reaction by a different enzyme family produces ethyl sulfate (EtS), a companion metabolite that often gets tested alongside EtG.

Several enzyme variants contribute to EtG production. Research using human liver tissue and individual recombinant enzymes has identified UGT1A9 and UGT2B7 as the two most active, together accounting for roughly half of the glucuronidation activity measured in liver microsomes.² Earlier work also flagged UGT1A1 and 2B7 as major contributors, with multiple other isoforms chipping in to a lesser degree.³ The redundancy matters: because several enzymes can do the job, genetic variation in any single one is unlikely to shut EtG production down entirely. That said, the extent to which common genetic polymorphisms shift how much EtG a given person produces from the same dose of alcohol remains an open question that researchers have flagged for further study.⁴

How Long EtG Stays Detectable in Urine

The reason EtG became popular for monitoring is its detection window. Ethanol itself disappears from urine within hours, but EtG sticks around much longer. In a controlled study where ten men drank a moderate dose of alcohol on an empty stomach, the total EtG recovered in urine over the following two days had a median of about 30 milligrams, representing a tiny fraction of the ethanol dose.⁵ Urinary concentrations peaked roughly six hours after the start of drinking and declined from there.⁶

In clinical and forensic practice, the commonly cited detection window for urinary EtG is about three to five days after drinking, though the actual window depends on how much alcohol was consumed, individual metabolism, hydration, and kidney function.⁷ After just one glass of wine or a single beer, EtG can remain above common screening thresholds for about a day but typically falls below them within 24 hours.⁸ A heavy drinking episode pushes the window out considerably further. The early characterization of EtG noted that it could be detected up to 80 hours after alcohol had been completely cleared from the body, filling a detection gap that no other biomarker covered at the time.⁹

The False-Positive Problem

EtG’s sensitivity is a double-edged sword. The test picks up ethanol exposure from sources that have nothing to do with drinking, and this has been one of the most contentious issues in its real-world use.

Hand sanitizers are a major culprit. Most commercial hand sanitizers contain 60% or more ethanol, and enough of it absorbs through the skin or is inhaled during normal use to generate detectable EtG in urine. In one study, volunteers who used an ethanol-based hand sanitizer eight times over eight hours under normal conditions produced urinary EtG concentrations as high as 103 ng/mL; with excessive application, levels reached 713 ng/mL.¹⁰ A more extreme protocol, in which volunteers applied hand sanitizer every five minutes for ten hours on three consecutive days, pushed EtG levels above 2,000 ng/mL, well past common screening cutoffs.¹¹ A study on propyl alcohol-based sanitizer even found false-positive results on the EtG immunoassay screen, with readings up to 4 mg/L after normal use and nearly 0.9 mg/L from passive inhalation of the vapor alone.¹²

Food and non-alcoholic beverages add another layer of complication. “Non-alcoholic” beers, which can contain up to 0.5% alcohol by volume, produced positive EtG results at a 0.1 mg/L cutoff for up to 13 hours after ingestion. Sauerkraut caused positives for up to five hours, and ripe bananas for about three and a half hours.¹³ One particularly striking finding involved volunteers who drank large amounts of non-alcoholic beer: in one participant, EtG and EtS accumulated overnight and reached concentrations of 14.1 mg/L and 16.1 mg/L by morning, levels that would look very much like real drinking to most screening programs.¹⁴ Mouthwash containing high concentrations of ethanol is another known source, though a study found that using it four times daily did not push results above a 500 ng/mL cutoff.¹⁵

Cutoff Levels and Why They Are Still Debated

The choice of where to draw the line between “positive” and “negative” is the single biggest practical headache with EtG testing. A lower cutoff catches more drinking episodes but also catches more incidental exposure. A higher cutoff reduces false positives but misses lighter drinking entirely.

In abstinence monitoring, a cutoff of 0.1 mg/L (100 ng/mL) is sometimes used, but research has shown it is too low to reliably separate intentional drinking from environmental ethanol. After a single glass of wine or a beer, EtG levels above 0.1 mg/L persisted for over 23 hours; at a 0.5 mg/L cutoff (500 ng/mL), three-quarters of urine samples were negative by 24 hours.¹⁶ But the same researchers concluded that even the 0.5 mg/L cutoff is not suitable for proving abstinence, because a person could drink a small amount and test negative the next day. For EtS, a threshold of 0.05 mg/L showed more promise as a cutoff for ruling out repeated intake, though the authors emphasized the need for further validation.

The 500 ng/mL cutoff does appear to distinguish actual beverage drinking from mouthwash exposure in most cases.¹⁷ But as the hand-sanitizer data showed, sustained occupational exposure can blow past that threshold. This creates real problems for healthcare workers, who may use hand sanitizer dozens of times a day and are also, in some professional monitoring programs, the very population being tested for alcohol abstinence.

Bacterial Contamination and Sample Handling

EtG results can go wrong in a different direction, too. If a urine sample sits at room temperature and contains bacteria, particularly common strains like E. coli, two things can happen. First, bacteria with beta-glucuronidase activity can break down EtG that is already there, producing a false-negative result. Second, if the sample contains residual ethanol (either from the donor or from environmental contamination), the bacteria can synthesize new EtG, creating a false positive. In one study, high EtG concentrations ranging from 0.5 to 17.6 mg/L appeared during storage in about a third of E. coli-infected urine samples that contained ethanol.¹⁸

EtS behaves differently here and that difference is diagnostically useful. When researchers incubated bacterial colonies with both EtG and EtS, E. coli and Clostridium sordellii completely degraded EtG within three to four days, but EtS remained intact.¹⁹ This is one of the strongest arguments for testing EtG and EtS together: if a sample shows a high EtG but no corresponding EtS, bacterial synthesis is a plausible explanation. If EtG is absent but EtS is present, bacterial degradation of EtG should be suspected. Concordance between the two markers strengthens confidence in the result.

Can You Beat the Test by Drinking Water?

A common assumption is that drinking large volumes of water before providing a urine sample will dilute EtG below detectable levels, similar to strategies sometimes tried with drug testing. The evidence suggests this is less effective than people think. A study of urine specimens from participants in a controlled abstinence program found that EtG-positive samples actually had higher average creatinine concentrations than EtG-negative ones, likely because alcohol itself has a late antidiuretic effect that concentrates the urine. The researchers concluded that attempts to dilute urine by drinking fluids before voiding are less effective for EtG and EtS compared with illicit drugs excreted in urine.²⁰ Labs also typically measure creatinine in the sample and flag specimens that appear overly dilute, adding another layer of difficulty to dilution strategies.

EtG in Hair and Fingernails

While urinary EtG captures a window of a few days, hair EtG extends the lookback period to months. As hair grows, EtG from the bloodstream becomes incorporated into the strand, creating a rough timeline of alcohol consumption that can stretch as far back as the hair is long. In a study comparing hair and fingernail EtG to self-reported drinking, both matrices showed moderate correlations with average weekly alcohol intake over the preceding 12 weeks, with hair showing a correlation of 0.53 and fingernails 0.57.²¹

Hair testing comes with its own major caveat: cosmetic treatments can dramatically reduce EtG concentrations. Bleaching reduced hair EtG by a mean of about 74% in one study, while perming caused a mean reduction of nearly 96%, essentially wiping out the signal.²² Another study found bleaching and permanent coloring reduced EtG by about 82% and 65%, respectively, with more treatments causing greater reductions.²³ Even gentler treatments like henna and semi-permanent dyes caused reductions that exceeded 10% in every case, and some reduced EtG to zero.²⁴ Anyone interpreting a hair EtG result needs to know the person’s cosmetic history, or the result could understate actual drinking by a wide margin.

How EtG Compares to Other Alcohol Biomarkers

Traditional blood tests for heavy drinking include liver enzymes like GGT, AST, and ALT, as well as carbohydrate-deficient transferrin (CDT). These are indirect markers: they rise when the liver or other systems are affected by chronic heavy use, but they can also be elevated for entirely unrelated reasons. In a pilot study of heavy drinkers referred for detoxification, hair EtG detected heavy alcohol use with a sensitivity of 94%, outperforming CDT at 64%, AST and ALT at 67% each, and nearly matching GGT at 93%.²⁵ In a liver transplant setting, urinary EtG reached a sensitivity of about 89% and a specificity of about 99% for detecting recent alcohol consumption, vastly outperforming CDT’s sensitivity of 25%.²⁶

A newer competitor is phosphatidylethanol (PEth), a phospholipid that forms in red blood cell membranes when ethanol is present. PEth is measured in whole blood and has a detection window of roughly two to four weeks, sitting between urinary EtG’s short window and hair EtG’s long window. In a study of participants in professional health programs, blood PEth at a 20 ng/mL cutoff detected alcohol use more frequently than urinary EtG or EtS at cutoffs of 100 and 25 ng/mL, respectively.²⁷ PEth was particularly good at flagging people with diagnosed alcohol use disorders, while urinary EtG and EtS were more likely to catch isolated drinking events in people without that diagnosis. In driving fitness assessments, PEth and hair EtG agreed about 68% of the time, with PEth responding faster to changes in drinking behavior because of its shorter lookback window.²⁸

No single biomarker covers every clinical question. Urinary EtG excels at catching a recent lapse within the past few days. Hair EtG provides a months-long drinking history. PEth offers a middle ground. And traditional markers, despite their lower sensitivity, are cheap, widely available, and useful as screening tools in routine blood panels. Transplant programs and professional monitoring boards increasingly use combinations of these markers rather than relying on any one alone.²⁹

EtG in Meconium and Prenatal Exposure

One of the more striking applications of EtG testing has nothing to do with monitoring adults. Meconium, the dark first stool a newborn passes, accumulates substances the fetus was exposed to during the second and third trimesters. EtG and EtS in meconium serve as objective biomarkers of prenatal alcohol exposure, addressing a problem that is difficult to solve through self-report alone, since many mothers underreport drinking during pregnancy. Research comparing meconium EtG and EtS to meconium fatty acid ethyl esters (another class of alcohol metabolites) and to maternal and neonatal hair concluded that meconium was the best matrix for evaluating intrauterine ethanol exposure, with EtG and EtS performing well as alternatives to fatty acid ethyl esters.³⁰

Longitudinal data have added weight to these findings. A cohort study followed children whose meconium was tested at birth and found that those classified as prenatally exposed based on a meconium EtG cutoff of 10 ng/g showed persistent negative effects on cognitive function from childhood into adolescence, even when the exposure was subclinical by conventional standards.³¹ This kind of biomarker-anchored research has reinforced public health messaging that there is no established safe threshold for alcohol consumption during pregnancy, and it has made meconium EtG testing a growing area of interest in perinatal medicine.

Forensic and Postmortem Complications

In living patients, the challenges of interpreting EtG are manageable with proper protocols: collect the sample promptly, refrigerate or add a preservative, and test EtS alongside EtG. In forensic and postmortem work, the problems multiply. Decomposition introduces bacterial activity that can both create and destroy EtG, as the bacterial contamination studies demonstrated. Blood and tissue samples from a body that has been dead for even a short time may not reflect what was happening during life. The postmortem redistribution of substances between tissues adds further uncertainty.

Reviews of EtG’s forensic use have acknowledged that while the marker’s specificity for ethanol exposure, long detection window, and low detection limits make it attractive for accident investigation and postmortem assessment, challenges related to appropriate cutoffs, nonuniform laboratory reporting limits, sample stability, and microbial activity complicate interpretation in practice. The same qualities that make EtG useful for transplant clinics or professional monitoring boards, its sensitivity and persistence, become liabilities when applied to contexts where sample integrity cannot be guaranteed and the stakes include criminal or civil liability.

Workplace and Professional Monitoring

EtG testing has become embedded in monitoring programs for physicians, nurses, pilots, lawyers, and other licensed professionals who are in recovery from alcohol use disorders. These programs typically require regular, sometimes random, urine collections and use EtG as one layer in a broader monitoring strategy that may include self-report questionnaires, clinical interviews, and other biomarkers. The rationale is that even a brief relapse in a safety-sensitive role can be dangerous, and EtG’s ability to detect alcohol use days after the fact fills a gap that breathalyzers and standard blood tests leave open.³²

The tension in these programs is real. A healthcare worker who uses hand sanitizer between every patient interaction, as infection control requires, could produce a urinary EtG level that overlaps with light drinking. Programs that rely on a low cutoff without confirmatory EtS testing or without accounting for occupational exposure risk punishing people who are complying both with their recovery program and with basic hygiene standards. The Substance Abuse and Mental Health Services Administration (SAMHSA) issued an advisory years ago cautioning against using EtG as standalone evidence of drinking, recommending it instead as part of a broader clinical picture. That advisory has not stopped programs from leaning heavily on EtG results, and disputes over false-positive results remain common in legal and professional disciplinary proceedings.